Improving heart failure medication use for patients with limited access in Denver

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, prospective trial at Denver Health, adults with heart failure and reduced ejection fraction are assigned to either pharmacist-directed medication adjustment visits with simplified patient education materials or to standard care. The intervention arm uses scheduled pharmacy follow-up visits focused on titrating guideline-directed heart failure medications and providing patient-centered education. Primary feasibility outcomes include the number of intervention visits completed and the proportion of visits that result in medication adjustments, with additional clinical and process measures collected. Key exclusions include severe renal failure or dialysis, cirrhosis, inability to consent, and non-English/non-Spanish speakers, and all participants must receive care within the Denver Health system.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Diagnosis of HFrEF (EF ≤ 40%)
* Receiving care within DHHA system

Exclusion Criteria:

* Estimated glomerular filtration rate (eGFR) \< 25 mL/min/1.73 m² or receiving dialysis.
* Cirrhosis
* Inability to consent
* Non-English or non-Spanish speaking

Where it's running

• Denver Health and Hospital Authority
  Denver, Colorado, United States Recruiting

Study contacts

• Study coordinator: Ryan C Martin, MD, MPH
• Email: Ryan.Martin2@dhha.org
• Phone: 303-602-3899

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

  Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• NT-proBNP–guided heart failure screening for people 65+ in rural China

  This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.

  Recruiting Jiangsu Taizhou People's Hospital · Nanjing · NCT07885488

• Voice-based detection of heart failure deterioration using Noah Labs Vox

  This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.

  Recruiting Noah Labs · Boston, Massachusetts · NCT07870395

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.